ifn-kinoid
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02665364)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Interferon alpha-1/13Immunity, active
Interferon alpha-1/13 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ifn-kinoid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02980198 | Phase 2 | Nov 1, 2016 | Neovacs |
| NCT02665364 | Phase 2 | Sep 1, 2015 | Neovacs, Université catholique de Louvain |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neovacs | For profit | 2 | 2 | 1 | 2015 |
| Université catholique de Louvain | Academic/Hospital | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1